Actively Recruiting
Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA
Led by Sohag University · Updated on 2024-09-19
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the macular vascular density in people with high myopia who do not have pathological myopic maculopathy. This cross-sectional observational study involves about 50 patients attending the ophthalmology outpatient clinic at Sohag Teaching Hospital. The study aims to understand vascular changes in the retina using a specialized imaging technique called optical coherence tomography angiography (OCTA). Participants will undergo evaluation with OCTA to measure their macular vascular density and central macular thickness. The study includes myopic patients with a spherical refractive error of -6 or more, and excludes those with other ocular or systemic diseases affecting eye circulation, previous eye surgeries or injuries, or pathological myopic maculopathy conditions. OCTA will also help exclude patients with pathological changes. During the study, patients will be assessed using OCTA scans and OCT imaging to gather data on retinal vascular density and macular thickness. The main outcome measured is the vascular density in high myopes over six months. Participants will attend outpatient clinic visits for these evaluations, with no treatment administered as part of the study. The study is sponsored by Sohag University and is expected to end in October 2025.
CONDITIONS
Brief Title
Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All myopic patients with axial high myopia (-6 spherical refractive error or more) of different age groups
You will not qualify if you...
- History of any other ocular diseases or systemic diseases that may affect ocular circulation
- Previous intraocular surgery or ocular injury
- Presence of pathological myopic maculopathy such as epiretinal membrane, foveoschisis, macular holes, lamellar holes, Lacquers cracks, choroidal neovascularization, or retinal atrophy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single visit at enrollment
Participants undergo optical coherence tomography angiography (OCTA) to evaluate macular vascular density and to exclude patients with pathological myopic maculopathy.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Sohag University
Sohag, Sohag Governorate, Egypt, 82524
Actively Recruiting
Research Team
S
Sara Magdy Mohammed, Master degree
I
Islam Awny Ahmed, Ass. Prof
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here